1 |
Nelson, C. J., Nandy, N., & Roth, A. J. (2007). Chemotherapy and cognitive deficits: Mechanisms, findings, and potential interventions. Palliative and Supportive Care, 5, 273-280. http://dx.doi.org/10.1017/S1478951507000442
|
2 |
Noal, S., Levy, C., Hardouin, A., Rieux, C., Heutte, N., Segura, C., et al. (2011). One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. International Journal of Radiation Oncology, Biology, Physics, 81, 795-803. http://dx.doi.org/10.1016/j.ijrobp.2010.06.037
DOI
|
3 |
Ouimet, L. A., Stewart, A., Collins, B., Schindler, D., & Bielajew, C. (2009). Measuring neuropsychological change following breast cancer treatment: An analysis of statistical models. Journal of Clinical and Experimental Neuropsychology, 31, 73-89. http://dx.doi.org/10.1080/13803390801992725
DOI
|
4 |
Quesnel, C., Savard, J., & Ivers, H. (2009). Cognitive impairments associated with breast cancer treatments: Results from a longitudinal study. Breast Cancer Research and Treatment, 116, 113-123. http://dx.doi.org/10.1007/s10549-008-0114-2
DOI
|
5 |
Isaki, E., Spaulding, T. J., & Plante, E. (2008). Contributions of language and memory demands to verbal memory performance in language-learning disabilities. Journal of Communication Disorders, 41, 512-530. http://dx.doi.org/10.1016/j.jcomdis.2008.03.006
DOI
|
6 |
Jansen, C. E., Miaskowski, C. A., Dodd, M. J., & Dowling, G. A. (2007). A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer. Oncology Nursing Forum, 34, 997-1005. http://dx.doi.org/10.1188/07.ONF.997-1005
DOI
|
7 |
Bender, C. M., Sereika, S. M., Berga, S. L., Vogel, V. G., Brufsky, A. M., Paraska, K. K., et al. (2006). Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology, 15, 422-430. http://dx.doi.org/10.1002/pon.964
DOI
|
8 |
Rosenthal, R. (1991). Meta-analytic procedures for social research. Newbury Park, CA: Sage Publications.
|
9 |
Scottish Intercollegiate Guidelines Network. (2011). SIGN 50: A guideline developer's handbook. Retrieved January, 11, 2012, from http://www.sign.ac.uk/pdf/sign50.pdf
|
10 |
Braver, T. S., & Barch, D. M. (2002). A theory of cognitive control, aging cognition, and neuromodulation. Neuroscience and Biobehavioral Reviews, 26, 809-817. http://dx.doi.org/10.1016/S0149-7634(02)00067-2
DOI
|
11 |
Collins, B., Mackenzie, J., Stewart, A., Bielajew, C., & Verma, S. (2009). Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psycho-Oncology, 18, 134-143. http://dx.doi.org/10.1002/pon.1379
DOI
|
12 |
Cusimano, A. (2001). Learning disabilities: There is a cure. Pennsylvania, PA: Achieve Publications.
|
13 |
Debess, J., Riis, J. O., Engebjerg, M. C., & Ewertz, M. (2010). Cognitive function after adjuvant treatment for early breast cancer: A population-based longitudinal study. Breast Cancer Research and Treatment, 121, 91-100. http://dx.doi.org/10.1007/s10549-010-0756-8
DOI
|
14 |
DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177-188. http://dx.doi.org/10.1016/0197-2456(86)90046-2
DOI
|
15 |
Egger, M., Davey Smith, G. D., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. British Medical Journal, 315, 629-634. http://dx.doi.org/10.1136/bmj.315.7109.629
DOI
|
16 |
Falleti, M. G., Sanfilippo, A., Maruff, P., Weih, L., & Phillips, K. A. (2005). The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature. Brain and Cognition, 59, 60-70. http://dx.doi.org/10.1016/j.bandc.2005.05.001
DOI
|
17 |
Fan, H. G., Houede-Tchen, N., Yi, Q. L., Chemerynsky, I., Downie, F. P., Sabate, K., et al. (2005). Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1-and 2-year follow-up of a prospective controlled study. Journal of Clinical Oncology, 23, 8025-8032. http://dx.doi.org/10.1200/JCO.2005.01.6550
DOI
|
18 |
Kim, G. D., Chung, B. Y., Kim, K. H., Byun, H. S., & Choi, E. H. (2011). Analysis of a trend of instrument usage to assess cognitive function of breast cancer patients undergoing chemotherapy. Journal of Korean Oncology Nursing, 11, 179-185. http://dx.doi.org/10.5388/jkon.2011.11.3.179
DOI
|
19 |
Stewart, A., Bielajew, C., Collins, B., Parkinson, M., & Tomiak, E. (2006). A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. The Clinical Neuropsychologist, 20, 76-89. http://dx.doi.org/10.1080/138540491005875
DOI
|
20 |
Tager, F. A., McKinley, P. S., Schnabel, F. R., El-Tamer, M., Cheung, Y. K., Fang, Y., et al. (2010). The cognitive effects of chemotherapy in post-menopausal breast cancer patients: A controlled longitudinal study. Breast cancer Research and Treatment, 123, 25-34. http://dx.doi.org/10.1007/s10549-009-0606-8
|
21 |
Knobf, M. T. (2011). Clinical update: Psychosocial responses in breast cancer survivors. Seminars in Oncology Nursing, 27, e1-e14. http://dx.doi.org/10.1016/j.soncn.2011.05.001
|
22 |
Korean National Statistical Office. (2009). Annual report on cause of death statistics. Seoul: Author.
|
23 |
Lezak, M. D., Howieson, D. B., & Loring, D. W. (2004). Neuropsychological assessment (4th ed.). New York, NY: Oxford University Press.
|
24 |
Matsuda, T., Takayama, T., Tashiro, M., Nakamura, Y., Ohashi, Y., & Shimozuma, K. (2005). Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients-evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer, 12, 279-287. http://dx.doi.org/10.2325/jbcs.12.279
DOI
|
25 |
Myers, J. S. (2009). Chemotherapy-related cognitive impairment. Clinical Journal of Oncology Nursing, 13, 413-421. http://dx.doi.org/10.1188/09.CJON.413-421
DOI
|
26 |
National Evidence-based Healthcare Collaborating Agency. (2011). NECA's guidance for systematic review for new health technology assessment. Seoul: Author.
|
27 |
Ahles, T. A., Saykin, A. J., McDonald, B. C., Li, Y., Furstenberg, C. T., Hanscom, B. S., et al. (2010). Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: Impact of age and cognitive reserve. Journal of Clinical Oncology, 28, 4434-4440. http://dx.doi.org/10.1200/JCO.2009.27.0827
DOI
|
28 |
Gazzaniga, M. S., Ivry, R. B., & Mangun, G. R. (2002). Cognitive neuroscience: The biology of the mind (2nd ed.). New York, NY: W.W. Norton & Company.
|
29 |
Glogoski, C., Milligan, N. V., & Wheatley, C. J. (2006). Evaluation and treatment of cognitive dysfunction. In H. M. Pendleton & W. Schultz-Krohn (Eds.), Pedretti's occupational therapy: Practice skills for physical dysfunction (6th ed.)(pp. 589-608). St. Louis, MO: Mosby Elsevier.
|
30 |
Ahles, T. A., & Saykin, A. J. (2002). Breast cancer chemotherapy-related cognitive dysfunction. Clinical Breast Cancer, 3(Suppl 3), S84-S90. http://dx.doi.org/10.3816/CBC.2002.s.018
DOI
|